Literature DB >> 10070899

Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells.

S A Burchill1, I J Lewis, P Selby.   

Abstract

Reverse transcriptase polymerase chain reaction (RT-PCR) is increasingly used to detect small numbers of circulating tumour cells, though the clinical benefit remains controversial. The largest single contributing factor to the controversy of its value is the different approaches to sample processing. The aim of this study was to compare the sensitivity and reproducibility of RT-PCR for the detection of tumour cells after four commonly used different methods of sample processing. Using RT-PCR, one tumour cell spiked in 2 ml of whole blood was detected after analysis of separated mononuclear cell RNA, whole blood total or poly-A+ RNA. No false positives were identified with any method. However, the reproducibility of tumour cell detection was reduced after isolation of the mononuclear cell fraction. Only analysis of poly-A+ RNA had a sensitivity of 100% in all the cell spiking experiments. In patient blood samples, analysis of poly-A+ RNA increased the number of blood samples positive for tyrosine hydroxylase (TH) mRNA compared with those positive after analysis of total RNA. This may reflect high levels of cDNA reducing the efficiency of the PCR. Isolation of poly-A+ RNA increases the sensitivity and reproducibility of tumour cell detection in peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070899      PMCID: PMC2362660          DOI: 10.1038/sj.bjc.6690155

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Detection of neuroblastoma cells in blood.

Authors:  T J Moss; D G Sanders
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

2.  International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Authors:  G M Brodeur; R C Seeger; A Barrett; F Berthold; R P Castleberry; G D'Angio; B De Bernardi; A E Evans; M Favrot; A I Freeman
Journal:  J Clin Oncol       Date:  1988-12       Impact factor: 44.544

3.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group.

Authors:  U Keilholz; M Willhauck; D Rimoldi; F Brasseur; W Dummer; K Rass; T de Vries; J Blaheta; C Voit; B Lethé; S Burchill
Journal:  Eur J Cancer       Date:  1998-04       Impact factor: 9.162

5.  Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.

Authors:  S A Burchill; F M Bradbury; P Selby; I J Lewis
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

6.  Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.

Authors:  T J Moss; C P Reynolds; H N Sather; S G Romansky; G D Hammond; R C Seeger
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

7.  Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.

Authors:  S A Burchill; F M Bradbury; B Smith; I J Lewis; P Selby
Journal:  Int J Cancer       Date:  1994-06-01       Impact factor: 7.396

8.  Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA.

Authors:  Y Miyajima; K Horibe; M Fukuda; K Matsumoto; S Numata; H Mori; K Kato
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

9.  Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

Authors:  D W Rogers; J G Treleaven; J T Kemshead; J Pritchard
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

Review 10.  The molecular detection of circulating tumour cells.

Authors:  P W Johnson; S A Burchill; P J Selby
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more
  5 in total

1.  Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.

Authors:  Jaw-Yuan Wang; Chan-Han Wu; Chien-Yu Lu; Jan-Sing Hsieh; Deng-Chyang Wu; Sung-Yu Huang; Shiu-Ru Lin
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

2.  Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.

Authors:  Nadia Dandachi; Marija Balic; Stefanie Stanzer; Michael Halm; Margit Resel; Thomas Anton Hinterleitner; Hellmut Samonigg; Thomas Bauernhofer
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

3.  Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival.

Authors:  Edlyn Soeth; Urte Grigoleit; Barbara Moellmann; Christian Röder; Bodo Schniewind; Bernd Kremer; Holger Kalthoff; Ilka Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2005-09-01       Impact factor: 4.553

4.  Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells.

Authors:  S A Burchill; L Perebolte; C Johnston; B Top; P Selby
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

Review 5.  Opportunities and challenges of circulating biomarkers in neuroblastoma.

Authors:  Ricky M Trigg; Jacqui A Shaw; Suzanne D Turner
Journal:  Open Biol       Date:  2019-05-31       Impact factor: 6.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.